Cargando…
Inhibition of human positive cofactor 4 radiosensitizes human esophageal squmaous cell carcinoma cells by suppressing XLF-mediated nonhomologous end joining
Radiotherapy has the widest application to esophageal squamous cell carcinoma (ESCC) patients. Factors associated with DNA damage repair have been shown to function in cell radiosensitivity. Human positive cofactor 4 (PC4) has a role in nonhomologous end joining (NHEJ) and is involved in DNA damage...
Autores principales: | Qian, D, Zhang, B, Zeng, X-L, Le Blanc, J M, Guo, Y-H, Xue, C, Jiang, C, Wang, H-H, Zhao, T-S, Meng, M-B, Zhao, L-J, Hao, J-H, Wang, P, Xie, D, Lu, B, Yuan, Z-Y |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649520/ https://www.ncbi.nlm.nih.gov/pubmed/25321468 http://dx.doi.org/10.1038/cddis.2014.416 |
Ejemplares similares
-
Positive selection on the nonhomologous end-joining factor Cernunnos-XLF in the human lineage
por: Pavlicek, Adam, et al.
Publicado: (2006) -
Requirement for XLF/Cernunnos in alignment-based gap filling by DNA polymerases λ and μ for nonhomologous end joining in human whole-cell extracts
por: Akopiants, Konstantin, et al.
Publicado: (2009) -
Nonhomologous end joining key factor XLF enhances both 5-florouracil and oxaliplatin resistance in colorectal cancer
por: Liu, Zhuo, et al.
Publicado: (2019) -
SFPQ•NONO and XLF function separately and together to promote DNA double-strand break repair via canonical nonhomologous end joining
por: Jaafar, Lahcen, et al.
Publicado: (2017) -
Nonhomologous DNA End Joining in Cell-Free Extracts
por: Sharma, Sheetal, et al.
Publicado: (2010)